OptimizeRx Q3 Adj EPS $0.09 Up From $0.07 YoY, Sales $16.33M Beat $15.01M Estimate
Portfolio Pulse from Benzinga Newsdesk
OptimizeRx (NASDAQ:OPRX) reported Q3 adjusted earnings of $0.09 per share, a 28.57% increase YoY. The company's quarterly sales were $16.33 million, beating the analyst consensus estimate of $15.01 million by 8.79% and marking an 8.25% increase YoY.
November 06, 2023 | 12:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
OptimizeRx reported a YoY increase in Q3 earnings and sales, beating analyst estimates. This positive financial performance could boost investor confidence.
OptimizeRx reported higher Q3 earnings and sales YoY, and also beat analyst estimates. This indicates a strong financial performance, which is likely to be viewed positively by investors and could lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100